Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pexacerfont for Reduction of Stress-Induced Food Craving and Eating in Humans

NCT01656577 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.

NCT NCT01656577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01656577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pexacerfont for Reduction of Stress-Induced Food Craving and Eating in Humans
Lead sponsor
National Institute on Drug Abuse (NIDA)
Phase
Phase 1
Overall status
Terminated
Start date
June 30, 2012
Completion date
September 30, 2015
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

daily oral pexacerfont for 28 days (300 mg/day loading dose for 7 days, followed, placebo